Akèy › Tit travay › Associate Director, Biostatistics

Associate Director, Biostatistics: Salè H-1B

58 aplikasyon kondisyon travay te itilize tit travay Associate Director, Biostatistics. Salè baz medyàn ofri $184,160; mwatye mitan $153,171–$200,000.

Demann (LCA)58

Salè medyan ofri$184,160

Mwatye salè yo$153,171–$200,000

10yèm–90yèm pousantaj$136,299–$214,200

Avoka imigrasyon, rekritè oswa anplwayè? Mete sèvis ou an tèt paj sa a — $99 pou 30 jou →

Anplwayè yo

Anplwayè	LCA	Salè medyan
Moderna Services, Inc.	10	$155,586
Novartis Pharmaceuticals Corporation	4	$164,476
Pfizer Inc.	4	$131,200
Alexion Pharmaceuticals, Inc.	3	$190,000
Insmed, Inc.	3	$214,200
Apellis Pharmaceuticals Inc.	2	$199,007
Revolution Medicines, Inc.	2	$212,750
Alnylam US, Inc.	2	$208,500
Incyte Corporation	2	$156,046
CSL Behring L.L.C.	2	$167,554
Foundation Medicine, Inc.	2	$134,066
BeOne Medicines USA, Inc.	2	$222,606
Mirati Therapeutics, Inc.	1	$190,000
Sunovion Pharmaceuticals Inc.	1	$194,685
Sarepta Therapeutics, Inc.	1	$185,000
BeiGene USA, Inc.	1	$175,000
Daiichi Sankyo, Inc.	1	$175,000
Jazz Pharmaceuticals, Inc.	1	$160,000
Sun Pharmaceutical Industries, Inc.	1	$202,878
Bristol-Myers Squibb Company	1	$193,368
Eisai Inc.	1	$200,000
Arrowhead Pharmaceuticals, Inc.	1	$190,000
Sumitomo Pharma America, Inc.	1	$166,400
Janssen Research & Development, LLC	1	$194,600
Servier Bio-Innovation LLC	1	$196,375
WCG Clinical, Inc.	1	$105,269
Relay Therapeutics, Inc.	1	$215,000
Vertex Pharmaceuticals Incorporated	1	$174,983
Regeneron Pharmaceuticals, Inc.	1	$234,675
TechData Service Company LLC	1	$200,000
Gilead Sciences, Inc.	1	$184,160
AbbVie Inc.	1	$191,000

Pa nivo salè

Nivo revni	Salè medyan
Nivo II (kalifye)	$202,500
Nivo III (eksperyans)	$184,580
Nivo IV (plen kompetans)	$175,781

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Pa ane fiskal

Ane fiskal	LCA	Salè medyan
FY2023	12	$180,000
FY2024	15	$190,000
FY2025	15	$142,200
FY2026	15	$200,000

Vil yo

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).